Hainan Poly Pharm Co Ltd (300630) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.015x

Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has a cash flow conversion efficiency ratio of 0.015x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.82 Million ≈ $6.56 Million USD) by net assets (CN¥3.01 Billion ≈ $440.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300630 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Hainan Poly Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2023)

This chart illustrates how Hainan Poly Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hainan Poly Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tridomain Performance Materials PT JK:TDPM	0.076x
SANUWAVE Health, Inc. Common Stock NASDAQ:SNWV	0.216x
XXL ASA OL:XXL	-0.085x
BARK, Inc. NYSE:BARK	0.021x
AEC SECURITIES BK:BYD-R	N/A
US Masters Residential Property Fund AU:URF	-0.030x
Chuwa Wool Industry Co Taiwan Ltd TW:1439	0.032x
Investigator Resources Ltd AU:IVR	-0.020x

Annual Cash Flow Conversion Efficiency for Hainan Poly Pharm Co Ltd (2016–2023)

The table below shows the annual cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023. For the full company profile with market capitalisation and key ratios, see Hainan Poly Pharm Co Ltd (300630) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	CN¥2.91 Billion ≈ $425.27 Million	CN¥112.72 Million ≈ $16.49 Million	0.039x	-79.66%
2022-12-31	CN¥2.80 Billion ≈ $410.10 Million	CN¥534.29 Million ≈ $78.18 Million	0.191x	+208.59%
2021-12-31	CN¥2.54 Billion ≈ $371.94 Million	CN¥157.03 Million ≈ $22.98 Million	0.062x	-62.06%
2020-12-31	CN¥2.04 Billion ≈ $298.39 Million	CN¥332.08 Million ≈ $48.59 Million	0.163x	-13.35%
2019-12-31	CN¥1.15 Billion ≈ $167.69 Million	CN¥215.37 Million ≈ $31.52 Million	0.188x	+75.14%
2018-12-31	CN¥883.26 Million ≈ $129.25 Million	CN¥94.79 Million ≈ $13.87 Million	0.107x	-17.46%
2017-12-31	CN¥721.37 Million ≈ $105.56 Million	CN¥93.79 Million ≈ $13.72 Million	0.130x	-28.09%
2016-12-31	CN¥307.12 Million ≈ $44.94 Million	CN¥55.53 Million ≈ $8.13 Million	0.181x	--

About Hainan Poly Pharm Co Ltd

SHE:300630 China Drug Manufacturers - Specialty & Generic

Market Cap

$73.10 Million

CN¥499.57 Million CNY

Market Cap Rank

#20527 Global

#4690 in China

Share Price

CN¥0.89

Change (1 day)

+0.00%

52-Week Range

CN¥0.89 - CN¥0.89

All Time High

CN¥70.54